Laura C. Gagnon - Vice President, Investor Relations James C. O'Rourke - President, Chief Executive Officer & Director Richard L. Mack - Chief Financial Officer & Executive Vice President Mike Rahm - Vice President, Market & Strategic Analysis Richard N. McLellan - Senior Vice President-Commercial

Andrew Wong - RBC Dominion Securities, Inc. Vincent Stephen Andrews - Morgan Stanley & Co. LLC Jacob Bout - CIBC World Markets, Inc. Don Carson - Susquehanna Financial Group LLLP Christopher S. Parkinson - Credit Suisse Securities (USA) LLC (Broker) Jonas Oxgaard - Sanford C. Bernstein & Co. LLC Joel Jackson - BMO Capital Markets (Canada) Ben Isaacson - Scotia Capital, Inc. (Broker) Jeffrey J. Zekauskas - JPMorgan Securities LLC Mark Connelly - CLSA Americas LLC Daniel Jester - Citigroup Global Markets, Inc. (Broker) Stephen Byrne - Bank of America Merrill Lynch John Roberts - UBS Securities LLC Michael Leith Piken - Cleveland Research Co. LLC Sandy H. Klugman - Vertical Research Partners LLC Yonah Weisz - HSBC Bank Plc (Tel Aviv Branch)

Good morning, ladies and gentlemen, and welcome to The Mosaic Company's First Quarter 2016 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode. After the company completes their prepared remarks, the lines will be opened to take your questions. Your host for today's call is Laura Gagnon, Vice President, Investor Relations of The Mosaic Company. Ms. Gagnon, you may begin.

Thank you. And welcome to our first quarter 2016 earnings call. Presenting today will be Joc O'Rourke, President and Chief Executive Officer; and Rich Mack, Executive Vice President and Chief Financial Officer. We also have other members of the senior leadership team available to answer your questions after our prepared remarks. The presentation slides we are using during the call are available on our website at mosaicco.com. We will be making forward-looking statements during this conference call. The statements include, but are not limited to, statements about future financial and operating results. They are based on management's beliefs and expectations as of today's date and are subject to significant risks and uncertainties. Actual results may differ materially from projected results. Factors that could cause actual results to differ materially from those in the forward-looking statements are included in our press release issued this morning and in our reports filed with the Securities and Exchange Commission. In addition, during the call, we will present both GAAP and non-GAAP financial measures. Reconciliations of GAAP and non-GAAP measures are included in the presentation slides and in today's press release. Now, I'd like to turn it over to Joc. James C. O'Rourke - President, Chief Executive Officer & Director: Good morning. Thank you for joining our call. Today, we're going to focus on the actions Mosaic is taking so that we can continue to successfully navigate in this market environment. The key concepts we want you to understand are: first, Mosaic's operational flexibility and solid balance sheet give us significant competitive advantages in a prolonged period of softer markets; second, we expect global demand for our products to be healthy, particularly in the second half of the year; and third, this management team has been through a number of cycles, and we have the…

Your first question comes from Andrew Wong with RBC Capital Markets.

So, I just wanted to touch on the Phosphate margin guidance. It's a bit better quarter-over-quarter, which is good. I guess that's some of the input cost savings. But I think it's fair to say that it remains quite weak. So, in the presentation and in your prepared comments, you've mentioned that the Phosphate gross margin will go up to 15% to 20% in the second half of this year. Can you just talk about how much of that improvement will be driven by price versus benefit from lower input costs? Thanks. James C. O'Rourke - President, Chief Executive Officer & Director: Thank you, Andrew. Yeah. Let me start; Joc O'Rourke here. Let me start by saying, certainly, we do expect some price increases in the second half, as demand really takes off around the globe. And I think to really put the phosphate market into its best perspective, I'm going to let Mike just talk about what he expects for global demand towards the second half, which is really what's going to drive our second half results in Phosphate. Mike? Mike Rahm - Vice President, Market & Strategic Analysis: All right, thanks, Joc, and good morning, Andrew. Yeah. We have not changed our view on phosphate demand. We actually nudged up our point estimate for global shipments to about 65.6 million tonnes, and we narrowed our range from 65 million to 67 million to 65 million to 66 million. If you look around the globe at some of the key markets, several positive developments there. In the case of India, I think there's a growing optimism, as far as demand prospects due to a forecast for an above-normal monsoon. You've had some strengthening of the rupee. And we have a very workable subsidy scheme that was introduced at the beginning of their fiscal year. When you look at a country like Brazil, local currency prices of key commodities like oils, like soybeans, sugar, coffee, are at near all-time highs. We think that underpins very good demand. You look at the fact that there's been an early release of more credit. So, farmers have greater flexibility. The product is moving to the farm, so a lot of positive developments that make us optimistic for second half demand. James C. O'Rourke - President, Chief Executive Officer & Director: So, what that means, Andrew, in terms of margin, is, yes, we expect some price improvement. We certainly expect the raw material inputs will benefit from that as they fall through our products. And just as importantly, you've seen our operating costs that we've really have worked hard to reduce and as operating rates go back to more normal rates as this demand picks up, our costs will further decline. So, we expect to see, as we said earlier, pretty normal margin rates in the second half.

Your next question comes from Vincent Andrews with Morgan Stanley. Vincent Stephen Andrews - Morgan Stanley & Co. LLC: Thanks, and good morning, everyone. Joc, I'm wondering if you have a view on whether or not Canpotex should consider shipping into Europe at all, just given there's European assets starting up in Canada and there's been an increase of imports into the U.S. over the past couple of years. James C. O'Rourke - President, Chief Executive Officer & Director: Yeah, I guess, at this stage, as you're aware, Canpotex – sorry, Vincent, welcome. At this stage, as you're aware, Canpotex doesn't ship a lot into Europe, although we do ship into Europe. I guess probably today, our disadvantage from a freight perspective probably makes Europe a less attractive market. And if you think about the markets as what goes to one place offsets somewhere else, we're focusing on the areas where we can compete the best. I'm going to let Rick just give a little more color, if he likes, to that.

Yeah, good morning, Vincent. Canpotex ships into Europe today mostly to industrial accounts that need white potash, and that ends up being a very good market. And I think Joc hit it. When we look at the freight grid, we're much better off going to other markets than we are going into Europe.

Your next question comes from Jacob Bout with CIBC.

Good morning. So, I think in your preamble there, you were talking or hinting about further asset rationalization in the Potash division. And just wanted to get your thoughts on how you're thinking about K3. Is there a possibility that you ramp up the CapEx spend there and then have the ability to shut down K1, K2? You guys could lower your operating costs as well. James C. O'Rourke - President, Chief Executive Officer & Director: Well, good morning, Jacob. Welcome. Thank you for the question. Certainly, when we talk about asset rationalization, we're talking about across our global footprint. We've proven before that we can optimize our costs in some time. In terms of K3, we continue to drive K3 at an accelerated rate. Although we've reduced capital this year, we have done nothing to impact the critical path of K3. And certainly in early next decade, we'll fully understand where the market is for that, and we'll be making decisions on K3 based on those market conditions at the time. So, we continue to match our production and sales with global demand, and we'll rationalize our assets to satisfy that demand. Thanks.

Your next question comes from Don Carson with Susquehanna.

Yes. Hello. Two questions on potash, one, I noticed your pricing was boosted by the industrial and feed, and I wonder how long that premium will last. Is that just a lag that will soon go away? And then, a broader question on Canpotex selling into Asia, you've got contract customers, yet we've seen cases, such as with India last year, where when the contract price is above the market price, they ask for an adjustment. And when you get into a delay in the negotiations over the new contract, it seems to paralyze the whole market. So, would Canpotex be better off moving to a spot basis with its Asian customers? James C. O'Rourke - President, Chief Executive Officer & Director: Okay. Don, I'm going to turn a lot of that over to Rick. I just start with your comment or question. Clearly, there are other ways we could be selling globally, including spot markets. And those discussions are, of course, being held in Canpotex, but I wouldn't want to discuss Canpotex's specific market strategies in this call for Mosaic. That would be something, I think, inappropriate for here, but, Rick, can you just talk about our pricing strategy in Canpotex in Asia?

Yeah, good morning, Don. In Asia, the two big markets there, India and China, have been contract markets. And I think Joc did a good job of portraying it. There probably needs to be some changes, but right now, when we're in (28:27) the midst of a discussion about that contract for the remainder of the year, it doesn't do any of us any good to speculate on whether we go contract or spot. Your second question on industrial and feed accounts -- those contracts have a lagging pricing formula. And those differences will become less as we get through into the second half of the year.

Okay. Thank you.

Your next question comes from Chris Parkinson of Credit Suisse. Christopher S. Parkinson - Credit Suisse Securities (USA) LLC (Broker): Perfect. Thank you very much. Can you just comment on your expectations for international phosphate prices, specifically in India and Southeast Asia, as recent tenders have been in the kind of 350-ish or even slightly lower range? You alluded to this in your prepared remarks, but, in general, how should we think about your intentions to participate at these levels or lack thereof, particularly if activity's already over-subscribed? And just any color on your expectations for netbacks would be greatly appreciated. Thank you. James C. O'Rourke - President, Chief Executive Officer & Director: Okay. Thanks, Chris. In terms of-- generally, I think I'm going to first just highlight that where the market pricing and over-participation, as you say, has been high, Mosaic has taken the position of actually walking away from those markets where we're not getting what we consider to be acceptable returns. Now, having said that, we are price-takers in the end, and we have to meet market. So in terms of our expectation for phosphate pricing in India, I think the issue there is really about the subsidies and what the retail prices are in India and how that fits in. And for that, I'm going to ask Rick and Mike to just touch on that. Mike Rahm - Vice President, Market & Strategic Analysis: Okay. Yeah, just a couple things in terms of possible second half pricing. One, I think we mentioned before that we think there could be a pretty strong bunching of demand. So we think Brazil will be in the market, India will be in the market, and North America in the fall fill will be all active at pretty much the same…

Yeah. I think, Mike, you've nailed it on the impact of India and Southeast Asia pricing. I think the good thing to look at is in the near-term, we've seen an uptick in prices into India and into Pakistan, which is a good first step at a time when Indians have deferred buying. So, when they come with full force, we think that creates a different pricing environment. And if I was an Indian buyer, I'd be stepping in and getting some cover at these levels. And as we look at what the impact is on netbacks, Joc talked about it earlier, but we see slight improvement in prices. We see the impact of raw materials in the second half hitting us positively, and we see the fact that with the plants running at more normalized operational rate, we see all those three things positively impacting our margins.

Your next question comes from Jonas Oxgaard with Bernstein. Jonas Oxgaard - Sanford C. Bernstein & Co. LLC: Hi, guys; morning. Two questions, if you don't mind. The first one, I was trying to reconcile the potash prices you had on slide seven, I think, you said $207 realized. And then, you guide to $180 to $200. Am I comparing apples-to-apples when looking at those two numbers? And the second question is completely different. You took down the CapEx both internally and for Ma'aden. Does that mean we're pushing out the start dates, particularly for Ma'aden, or how should I think about this? James C. O'Rourke - President, Chief Executive Officer & Director: Hi, Jonas. Good morning. Good to hear your voice. I'm going to hand both of those over to Rich Mack. I think the first question is really about the math and existing market rates. And then, the second question I think as a board member of Ma'aden, Rich can probably give you the most color. Richard L. Mack - Chief Financial Officer & Executive Vice President: Sure. Thanks, Joc, and good morning, Jonas. With respect to your first question, yes, it is apples-to-apples. And it really goes to, I think it was Don's question earlier and that is, we benefited in the first quarter from some of the industrial and K-Mag sales that are at higher prices compared to where they will be in the second quarter. Recently, we've seen a precipitous decline, for example, in SOP and that results in some recalibrating for K-Mag prices, just to give one example. And then on Ma'aden, what you should assume there is this is basically a timing issue with respect to capital. We would effectively guide exactly as we have in the past and that is ammonia production will start in the fourth quarter of this year. I think we are anticipating somewhere in the vicinity of 300,000 tonnes of ammonia that will be produced out of the Ma'aden joint venture in 2016. Phosphate production will start sometime in the middle part of 2017. Both of those points in time are generally consistent with what we talked about previously. So, think of the deferral in capital in 2016 related to Ma'aden to be something that will be picked up in 2017.

Next question comes from Joel Jackson with BMO Capital Markets.

Hi. Good morning. Wondering if you could talk a little bit about the strategy in Brazil on potash, my understanding was the distribution arm, your distribution arm, bought tonnes from Eastern European suppliers this past few months to try to ease some of the burden in the country. And also, I know a few months ago when prices were as low $210 a tonne, your distribution arm was going in and trying to buy tonnes and couldn't. Can you talk about now if you're going in and trying to buy tonnes at $215 and $220, if you're finding volume from European competitors on potash? Thanks. James C. O'Rourke - President, Chief Executive Officer & Director: Hi. Good morning, Joel. Thanks. I'm going to just hand this straight over to Rick. This question's come up before and I think we need to probably nip it.

Yeah. Good morning, Joel, and thanks for your question. As far as our Distribution business, we did step in and buy tonnes outside of – Canpotex is our primary supplier, in fact, our sole supplier, but we did step in during a period where they had less tonnes going to the market and bough some from third parties. That continues into the second quarter. It's not a huge amount of tonnes. And frankly, we've been able to manage through kind of a tightness in the marketplace, so that's first. There was some question of us buying up some tonnes in North America and trying to move them into our own Distribution business taking an arbitrage on the price spreads from the center Gulf to move them into our Brazil business. That, we could not collect up enough to make a vessel truly work, but that arbitrage is there. And if prices remain lower in North America, that would sure lead the opportunity for somebody to play that game.

Your next question comes from Ben Isaacson with Scotiabank.

Hi. Thank you. Just looking at Slide 23 on P&K shipments to China and I was wondering if you could talk a little bit about how influential China is on your Phosphate business, particularly with respect to do you see net capacity growing or shrinking over the next couple of years? Are the Chinese price-setters either all year or perhaps on a seasonal basis? And are the Chinese disciplined when it comes to phosphate production? Thank you. James C. O'Rourke - President, Chief Executive Officer & Director: Thanks, Ben. Most of this I'm just going to hand over to Mike, who really spends a lot of time analyzing this market very carefully. And I think, though, I will say in general our expectations. And I think if you read the major analyst companies, their expectation is Chinese capacity over time will remain flat and will possibly shrink. So, that's basically what's in our plan. But I think to give better detailing, I'm going to hand it straight to Mike. Mike Rahm - Vice President, Market & Strategic Analysis: Sure. Good morning, Ben. I guess several components to that question. Let's talk about the export numbers first. According to Chinese Customs Statistics, first quarter exports were down about 560,000 tonnes from a year ago. We think that that will continue in the last three quarters of the year. And our last estimate from our Chinese team indicates that we believe that Chinese exports will be down about 2 million tonnes for the year, from the record 11.7 million last year to about 9.6 million tonnes this year. As you know, the Chinese have stopped building phosphate plants after this dramatic expansion over the past 10 years. And, as Joc mentioned, we think that there will be some restructuring that takes place in what's a very heterogeneous industry there. And that over time, exports probably will stabilize somewhere in that 7 million to 8 million tonne range. There is an analog, if you looked at what happened on the nitrogen side of the business. I think 2015 was the first year where closures of ammonia capacity exceeded increases in capacity. And so, capacity in China can decline. And we think that over the next five years, you will see a significant restructuring and China becomes certainly a large, but a more stable player in our market.

Your next question comes from Jeff Zekauskas with JPMorgan.

Thanks very much. You talked about the cycle being cyclically weak at this juncture. Notwithstanding that, is it the case that you'd contemplate any meaningful acquisitions? And should you make them, how much are you willing to leverage your balance sheet? James C. O'Rourke - President, Chief Executive Officer & Director: Okay. Jeff, good morning. Thank you. So, if I understand, are we contemplating acquisitions and what would we be willing to lever? Let me start this off, and then I'm going to hand it to Rich, but yeah, we look at this part of the cycle, and we're actively looking for opportunities to grow our company over the long term. And we believe this part of the cycle may be opening up opportunities for value that might not exist in other parts of the cycle. That being said, our basic philosophy is any acquisition we make has to meet a return on capital requirement, that meets cost to capital, plus a risk premium, plus a return to shareholders. And then with the share price where it is today, we have the added need of it having to compete with the potential to just buy back our own shares. In terms of leveraging up, yes, we would be able to lever up. And we have said before we would go beyond our normal 2-to-1 debt-to-EBITDA ratio for the right investment, but realize that we are very conscious of our credit rating, and we're committed to maintaining that. Now, having said that, we expect any acquisition would come with its own earnings, which would offset some of that. Rich, do you want to add some color to that? Richard L. Mack - Chief Financial Officer & Executive Vice President: I think you've covered it, Joc. I would just say, Jeff, Mosaic will be disciplined through any process that we undertake. And I think we've noted this before. Mosaic was essentially evolved through acquisitions during the down part of the cycle. And so there certainly are opportunities that come in front of us. I've mentioned before almost any phosphate or potash opportunity will come across our desk. And if the circumstances are right, we have the balance sheet capability to do it. And we definitely will stay disciplined, and we are committed to maintaining an investment grade credit rating. James C. O'Rourke - President, Chief Executive Officer & Director: And one other point, Jeff. I just want to make, this discipline means we're going to be just as happy to walk away from things if we can't get them at a price that we believe adds real value to our shareholders.

Your next question is from Mark Connelly with CLSA.

Joc, you mentioned declining farm income in your opening comments, but how significant a role has that actually played with nutrient prices going down? And as I measure it, nutrients got cheaper and farm income didn't really go down that much in North America this year. So, I'm just curious. You listed it as one of several issues, but how big is it really? James C. O'Rourke - President, Chief Executive Officer & Director: Thanks, Mark. And actually, it's a great point. Rick and I were with one of our major customers just last week, and they have a relatively detailed analysis of the different costs. And of all the costs, I think potash and phosphate amounted to $61 per acre on a farm in your Indiana-Illinois-type area. Interestingly enough, you're glyphosates and chemicals came to a higher number than that. Nitrogen came to over $100 and seed well over $100. So, if you look at a farmer and affordability from just that analysis, it really says that if a farmer wants to maximize his revenue from every acre, the last thing you should be doing today is compromising the amount of fertilizer he puts down. Rick, did you want to add anything to that?

No. And I think that the changes in commodity prices have truly been positive, given where crop nutrient prices are at. I think the issue is is that in a period with everyone, where farmers have lived with prices that are much higher than they are today, there is a percentage of farmers that, at today's prices and nutrient costs and all the inputs, aren't going to make money. And I think that's one thing. That's why we mentioned it is that we're going to go through a period where we just have to understand what real farm income is. And whether it's in Brazil or in North America, we see those things happening. Mike? Mike Rahm - Vice President, Market & Strategic Analysis: The other thing -- if you just look at North American shipments of potash and phosphate, I mean, they have been remarkably constant for about the last five years or since the financial crisis, and both of them right in that 9 million metric tonnes. So, while there might be front page stories in The Wall Street Journal about the difficulty of Farmer Jones in Decatur, Illinois, the proof is in the pudding as far as the actual shipments, and they've been very, very constant.

Your next question comes from P.J. Juvekar with Citigroup.

Hey. Good morning. This is Dan Jester on for P.J. Just want to clarify one thing. The $500 million cost savings program you announced a few years back -- is that complete? And if not, how much do you have left to get on that? And secondly, if I recall correctly, you were going to start a new sulfur melter this past quarter. Did that start up? And maybe talk about what the impact on your sulfur cost could be. Thanks. James C. O'Rourke - President, Chief Executive Officer & Director: Okay, Dan. Thanks a lot. Let me start with the $500 million. The $500 million program was a five-year program to take out reoccurring costs over that timeframe. We announced that three years ago. And I would say we are certainly on track for it, and probably a little bit ahead of track. We still have some areas where we think we can get some further reductions in both G&A and operating costs, but you can see in our results that a good chunk of that is flowing through our results today, as you're well aware. I mean, our Potash costs are flat, despite a 16% reduction in our operating rates. Our Phosphate conversion costs are lower, despite a significantly lower operating rate. And we've held our phosphate raw costs flat for several years. And all this is part of that program. You can see our SG&A costs this year down 10%. So, overall, you can see the results as they flow through, but we still have some cost left to come. But it's going very well. In terms of the sulfur melter, that sulfur melter is now running. Where that will probably have the biggest impact, and you've seen the sulfur prices in the Gulf come down recently. I think what it's done is it's forced the trade flow to go to what makes the best sense. And so what we will see in terms of costs is probably not a significant decrease, but what we will see is the center Gulf liquid sulfur market going down to trading at a discount to solid sulfur again, as it has five, 10 years ago.

Your next question comes from Steve Byrne with Bank of America.

Hi. Mike had a few remarks earlier about the outlook for India and Brazil. And I wanted to just drill into U.S. and China a bit here. And with respect to the U.S., given your view of fall applications of P&K and where the spring looks like it's trailing out here, would you say the P&K applications in this fertilizer year that we're in right now will fall short of historical levels or compared to, say, what was removed with last year's harvest? So, that's a U.S. question. One over on China -- it appears to us that crop yields in that country could be constrained by under-application of potash, in spite of over-application of nitrogen. Would be interested in your view on that and what do you think is the mechanism for those proportions to change over time? James C. O'Rourke - President, Chief Executive Officer & Director: All right. Thanks. Lot of questions, I'm going to hand it straight to Mike to go through this. We want to get through everybody's questions. Mike Rahm - Vice President, Market & Strategic Analysis: Okay. Yeah. Thanks, Steve, and good morning. And I'll make some comments and I think Rick probably has some comments as well. In the U.S., as far as the spring application season goes, I guess we would characterize it as a strong season. We're seeing good shipments, no indication of changes in application rates. And as we mentioned before, we believe that P&K shipments will continue to be in that 9 million metric tonne range. So that's the situation in the U.S. And obviously, the spring season is pretty much complete and history. And now, we're beginning to look ahead for fall season. And certainly, when you look at futures prices, you have corn and soybeans still at relatively high levels. Assuming there's a decent crop and a good pull of nutrients, we have no reason to think that the fall application season is going to let up at all. And I guess a positive in North America -- we think the pipeline has been pulled down to much more normal levels or even lower levels after seeing some elevated stocks. In China, yeah, I think your point is spot on. We expect that. As you know, China has announced zero growth policy after 2020. And they've also announced some changes in their crop support prices. And in terms of no growth, I think you'll see maybe a reallocation of nutrients from nitrogen into phosphate and especially potash. And I think there's some evidence of that taking place already, because last year, China had record potash imports of over 9 million tonnes, domestic production was up, and their potash shipments are on the rise. And I think that, clearly, is evidence of acknowledging the problem you bring up. Rick, do you have anything?

No. I think you've got it covered, Mike.

Your next question is from John Roberts with UBS.

Morning. Can you hear me? James C. O'Rourke - President, Chief Executive Officer & Director: Yep.

Thank you. If you don't get a Chinese potash agreement this quarter, I assume your full-year outlook would be worse because pent-up demand would continue to be deferred, but do you think that price would still be stable in that scenario? That is, do you think that price may have stabilized in part here because of expectations of a near-term agreement and things could get sloppy again if we don't get that? James C. O'Rourke - President, Chief Executive Officer & Director: I'm going to hand that straight to Rick just to answer that as a...

Good morning, John. Our expectation is for the contract to get completed with the Chinese during the second quarter. So, if it didn't happen, I think that how we operate would be to match up our production to what we believe the market is going to be. And we'll continue to operate that way.

Your next question is from Michael Piken with Cleveland Research.

Yeah, good morning. Just a couple of quick questions, the first one being, in terms of your longer-term strategy, I mean, if the market on potash, in particular, appears to be over-supplied, what is the potential for Canpotex producers to continue to cut production if other producers are running at very high operating rates, particularly those that are higher on the cost curve than you guys? James C. O'Rourke - President, Chief Executive Officer & Director: Okay. Look, let me start by saying, and I'm reiterating a point I think we've made a number times, which is we don't see the market as really being all that out of balance. You have a weak market today because of cyclicality. You've also had the impact of seasonality. And the two have combined to create a situation that's pretty difficult for that market. That being said, we believe once the normal flow starts, i.e., once the Chinese contract is in place, once India starts buying and they get a contract in place, the demand gets sopped up pretty darn quickly, and that everybody goes back to more normal operating rates. So, when you ask the long-term, our expectations are Canpotex and Mosaic will continue to match global demand with our available production, as we have in the first quarter. And that we don't see any reason for that to change at this point.

Your next question comes from Sandy Klugman with Vertical Research Partners.

Thank you. A couple questions, one, how has the challenging backdrop for growers impacted demand for higher margin products, such as MicroEssentials? Second question is any thoughts on how India's pending phosphoric acid settlement will impact the region's desire to import that versus producing the product locally? And then finally, on the longer-term supply demand balance from the phosphate industry, what are your thoughts on how quickly OCP will bring on new granulation capacity? James C. O'Rourke - President, Chief Executive Officer & Director: Okay. There's three there. Thanks, Sandy. There's three there. I'm going to try and get all three. First of all, MicroEssentials, our limit to selling MicroEssentials so far has been our production capacity. We have just completed a $225 million increase in capacity at our New Wales plant, which will give us the capacity to produce 3.5 million tonnes. As per the earlier question about the economics of buying fertilizer, we believe the economics of using MicroEssentials is better than it's ever been because of the challenging market, not despite the challenging market. So, I would say, first of all, we expect the careful producer will be doing everything they can to increase yield per acre, which includes using the best quality premium products, which would be like our MicroEssentials product or our K-Mag or any of those products that tend to bring on better yield. In terms of P2O5 to India, I'm going throw that straight over to Rick.

Yeah. Good morning. With P2O5, with the acid contract into India, I think there's already been contracts closed into Europe that are at higher levels. I think how the Indian producers think about their phosphoric acid contract is they're producing more NPKs because that allows them to maximize their return from the subsidy. And if you look, in our forecasts, we show less DAP being produced in India, which in turn leads to more imports. James C. O'Rourke - President, Chief Executive Officer & Director: And I'll just quickly touch on the OCP. Obviously, we don't have any information that you don't have that's been publicly stated, but OCP has publicly stated that they will contribute, I believe, half the world's growth by their granulation growth. So, I'm assuming that is exactly what they'll do. We have time for one last question on the thing here. So, let's keep moving.

You're next question is from Yonah Weisz with HSBC Bank.

Hi there. Thanks for taking the question. A question actually is on your balance sheet, and on some ideas of capital allocation. In the past, you've talked about keeping a $1 billion cash buffer on your balance sheet. There's a chance, I guess, with lower profits and good amount of capital spending, that you may eat into that buffer and go lower than $1 billion of cash on the balance sheet. So, I guess I'm curious to know how low can you go or do you want to go below that $1 billion mark for cash on the balance sheet before something critical happens, like you have to, for example, perhaps cut a dividend or take some serious cuts into your capital spending? James C. O'Rourke - President, Chief Executive Officer & Director: Well, thank you, Yonah. Let me quickly touch on this, and then I'll hand it to Rich for a second. But the liquidity buffer we carry is $2.5 billion, and exactly what the name implies, it is a buffer for short-term liquidity. Today, we have announced significant cost reductions, further capital reductions, to minimize the impact on that liquidity buffer. But if our cash needs exceed our short-term generation, we will dip into that buffer. Rich, do you want say anything on that? Richard L. Mack - Chief Financial Officer & Executive Vice President: Yeah. Yonah, I would say that you should just think of what our end goal here is to have about $2.5 billion of total available liquidity, and that can be comprised of either cash on balance sheet or available revolver capacity. And so, at times, that will fluctuate up and down. Today, we still have a very strong cash balance on our balance sheet. And we certainly, we believe with the conservative way…

Thank you for joining The Mosaic Company's first quarter 2016 earnings conference call. You may now disconnect.